About
Technology
Issues
FAQ
Links
Official Page
Health-related quality of life of carfilzomib- and daratumumab-based therapies in patients with relapsed/refractory multiple myeloma, based on German benefit assessment data
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.